Gerresheimer Ag Stock Performance
| GRRMF Stock | USD 51.41 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Gerresheimer are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Gerresheimer AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, Gerresheimer is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 58.4 M | |
| Total Cashflows From Investing Activities | -197 M | |
| Free Cash Flow | 8.4 M |
Gerresheimer |
Gerresheimer Relative Risk vs. Return Landscape
If you would invest 5,141 in Gerresheimer AG on September 29, 2025 and sell it today you would earn a total of 0.00 from holding Gerresheimer AG or generate 0.0% return on investment over 90 days. Gerresheimer AG is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Gerresheimer, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Gerresheimer Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gerresheimer's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Gerresheimer AG, and traders can use it to determine the average amount a Gerresheimer's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GRRMF |
Based on monthly moving average Gerresheimer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gerresheimer by adding Gerresheimer to a well-diversified portfolio.
Gerresheimer Fundamentals Growth
Gerresheimer Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Gerresheimer, and Gerresheimer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gerresheimer Pink Sheet performance.
| Return On Equity | 0.0852 | |||
| Return On Asset | 0.0338 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 3.29 B | |||
| Shares Outstanding | 31.4 M | |||
| Price To Earning | 17.23 X | |||
| Price To Book | 1.49 X | |||
| Price To Sales | 1.22 X | |||
| Revenue | 1.5 B | |||
| EBITDA | 293.93 M | |||
| Cash And Equivalents | 134.12 M | |||
| Cash Per Share | 4.27 X | |||
| Total Debt | 655 M | |||
| Debt To Equity | 0.99 % | |||
| Book Value Per Share | 41.00 X | |||
| Cash Flow From Operations | 212.08 M | |||
| Earnings Per Share | 3.09 X | |||
| Total Asset | 2.88 B | |||
About Gerresheimer Performance
By analyzing Gerresheimer's fundamental ratios, stakeholders can gain valuable insights into Gerresheimer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Gerresheimer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Gerresheimer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. The company was founded in 1864 and is headquartered in Dsseldorf, Germany. Gerresheimer operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10937 people.Things to note about Gerresheimer AG performance evaluation
Checking the ongoing alerts about Gerresheimer for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Gerresheimer AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Gerresheimer AG generated a negative expected return over the last 90 days | |
| Gerresheimer AG has accumulated 655 M in total debt with debt to equity ratio (D/E) of 0.99, which is about average as compared to similar companies. Gerresheimer AG has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Gerresheimer until it has trouble settling it off, either with new capital or with free cash flow. So, Gerresheimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Gerresheimer AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Gerresheimer to invest in growth at high rates of return. When we think about Gerresheimer's use of debt, we should always consider it together with cash and equity. | |
| Over 85.0% of Gerresheimer shares are owned by institutional investors |
- Analyzing Gerresheimer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gerresheimer's stock is overvalued or undervalued compared to its peers.
- Examining Gerresheimer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gerresheimer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gerresheimer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gerresheimer's pink sheet. These opinions can provide insight into Gerresheimer's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Gerresheimer Pink Sheet analysis
When running Gerresheimer's price analysis, check to measure Gerresheimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gerresheimer is operating at the current time. Most of Gerresheimer's value examination focuses on studying past and present price action to predict the probability of Gerresheimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gerresheimer's price. Additionally, you may evaluate how the addition of Gerresheimer to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |